Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
2.
World J Surg Oncol ; 19(1): 201, 2021 Jul 06.
Article in English | MEDLINE | ID: mdl-34229704

ABSTRACT

BACKGROUNDS: The lymphocyte to C-reactive protein (CRP) ratio (LCR) is an indicator of systemic inflammation and host-tumor cell interactions. The aim of this study was to investigate the prognostic significance of LCR in lower rectal cancer patients who received preoperative chemo-radiotherapy (CRT). METHODS: Forty-eight patients with lower rectal cancer who underwent CRT followed by curative surgery were enrolled in this study. Routine blood examinations were performed before and after CRT were used to calculate pre-CRT LCR and post-CRT LCR. The median LCR was used to stratify patients into low and high LCR groups for analysis. The correlation between pre- and post-CRT LCR and clinical outcomes was retrospectively investigated. RESULTS: The pre-CRT LCR was significantly higher than the post-CRT LCR (11,765 and 6780, respectively, P < 0.05). The 5-year overall survival rate was significantly higher for patients with high post-CRT LCR compared with low post-CRT LCR (90.6% and 65.5%, respectively, P < 0.05). In univariate analysis, post-CRT LCR, post-CRT neutrophil to lymphocyte ratio, and fStage were significant prognostic factors for overall survival. In multivariate analysis, post-CRT LCR, but not other clinicopathological factors or prognostic indexes, was a significant prognostic factor for overall survival (P < 0.05). CONCLUSIONS: Post-CRT LCR could be a prognostic biomarker for patients with lower rectal cancer.


Subject(s)
C-Reactive Protein , Rectal Neoplasms , Chemoradiotherapy , Humans , Lymphocytes/pathology , Neoplasm Staging , Prognosis , Rectal Neoplasms/pathology , Rectal Neoplasms/therapy , Retrospective Studies
3.
World J Emerg Surg ; 16(1): 17, 2021 03 30.
Article in English | MEDLINE | ID: mdl-33785047

ABSTRACT

BACKGROUND: "Dirty mass" is a specific computed tomography (CT) finding that is seen frequently in colorectal perforation. The prognostic significance of this finding for mortality is unclear. METHODS: Fifty-eight consecutive patients with colorectal perforation who underwent emergency surgery were retrospectively reviewed in the study. Dirty mass identified on multi-detector row CT (MDCT) was 3D-reconstructed and its volume was calculated using Ziostation software. Dirty mass volume and other clinical characteristics were compared between survivor (n = 45) and mortality groups (n = 13) to identify predictive factors for mortality. Mann-Whitney U test and Χ2 test were used in univariate analysis and logistic regression analysis was used in multivariate analysis. RESULTS: Dirty mass was identified in 36/58 patients (62.1%) and located next to perforated colorectum in all cases. Receiver-operating characteristic (ROC) curve analysis identified the highest peak at 96.3 cm3, with sensitivity of 0.643 and specificity of 0.864. Univariate analysis revealed dirty mass volume, acute disseminated intravascular coagulation (DIC) score, acute physiology and chronic health evaluation II (APACHE II) score, and sequential organ failure assessment (SOFA) score as prognostic markers for mortality (p<0.01). Multivariate analysis revealed dirty mass volume and APACHE II score as independent prognostic indicators for mortality. Mortality was stratified by dividing patients into four groups according to dirty mass volume and APACHE II score. CONCLUSIONS: The combination of dirty mass volume and APACHE II score could stratify the postoperative mortality risk in patients with colorectal perforation. According to the risk stratification, surgeons might be able to decide the surgical procedures and intensity of postoperative management.


Subject(s)
APACHE , Intestinal Perforation/diagnostic imaging , Intestinal Perforation/mortality , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Female , Humans , Imaging, Three-Dimensional , Intestinal Perforation/surgery , Male , Middle Aged , Predictive Value of Tests , Prognosis , Retrospective Studies , Sensitivity and Specificity
4.
Surg Laparosc Endosc Percutan Tech ; 31(3): 281-284, 2020 12 16.
Article in English | MEDLINE | ID: mdl-33347089

ABSTRACT

BACKGROUND: Anastomotic leakage is a feared complication of anterior resection for rectal cancer. Among the various factors reported to be involved in the occurrence of anastomotic leakage, blood perfusion of the remnant intestine is one of the most important. Recently, the usefulness of evaluating blood perfusion using indocyanine green (ICG) has been reported. We therefore aimed to show that measuring intestinal temperature using thermography is useful for evaluating blood perfusion. The authors also investigated the relation between intestinal temperatures and the ICG fluorescence time (FT). MATERIALS AND METHODS: Altogether, 45 patients who underwent laparoscopic anterior resection for rectal cancer between July 2017 and September 2018 were enrolled in this study. ICG FT and intestinal temperature were measured after the mesenteric dissection. RESULT: The temperature boundary could be easily identified using thermographic images. The temperature of the residual intestinal tract was significantly higher than that of the resected intestinal tract at the planned separation line (29.9 vs. 27.3°C). In addition, there was an inverse correlation between the ICG FT and the temperature of the residual intestine. CONCLUSION: Intestinal temperature measurement through thermography is a useful new tool for evaluating intestinal blood perfusion.


Subject(s)
Colorectal Surgery , Digestive System Surgical Procedures , Laparoscopy , Anastomosis, Surgical , Anastomotic Leak , Humans , Indocyanine Green , Perfusion
5.
J Med Invest ; 67(3.4): 285-288, 2020.
Article in English | MEDLINE | ID: mdl-33148903

ABSTRACT

BACKGROUND: Sometimes intraoperative urethral injury occurs in Transanal total mesorectal excision (TaTME). The aim of this study is to investigate the usefulness of indocyanine green (ICG) fluorescent catheter system for avoiding intraoperative urethral injury in TaTME in experimental model. METHODS: A urethral catheter was filled with the mixture of albumin and ICG and raw hams were applied in layers as the surrogate model of rectourethral muscle. The detectability of ICG fluorescence in this catheter was investigated by using laparoscope-type fluorescence camera system. RESULTS: Fluorescence was detected when ICG was mixed with albumin or peripheral blood. ICG fluorescence could be detected within 4 mm depth of layered raw hams as the surrogate model. Quantitative analysis of the picture detected that ICG fluorescence plateaued in lower concentration than that of serum. CONCLUSION: ICG fluorescent catheter system may be useful for avoiding intraoperative urethral injury in TaTME. J. Med. Invest. 67 : 285-288, August, 2020.


Subject(s)
Intraoperative Complications/prevention & control , Rectal Neoplasms/surgery , Rectum/surgery , Urethra/injuries , Urinary Catheters , Fluorescence , Humans , Indocyanine Green
6.
J Mol Med (Berl) ; 98(8): 1125-1137, 2020 08.
Article in English | MEDLINE | ID: mdl-32607871

ABSTRACT

Proinflammatory cytokines released from the pancreatic islet immune cell infiltrate in type 1 diabetes (T1D) cause insulinopenia as a result of severe beta cell loss due to apoptosis. Diabetes prevention strategies targeting different cytokines with antibodies in combination with a T cell antibody, anti-TCR, have been assessed for therapy success in the LEW.1AR1-iddm (IDDM) rat, an animal model of human T1D. Immediately after diabetes manifestation, antibody combination therapies were initiated over 5 days with anti-TNF-α (tumour necrosis factor), anti-IL-1ß (interleukin), or anti-IFN-γ (interferon) together with anti-TCR for the reversal of the diabetic metabolic state in the IDDM rat. Anti-TCR alone showed only a very limited therapy success with respect to a reduction of immune cell infiltration and beta cell mass regeneration. Anti-TCR combinations with anti-IL-1ß or anti-IFN-γ were also not able to abolish the increased beta cell apoptosis rate and the activated immune cell infiltrate leading to a permanent beta cell loss. In contrast, all anti-TCR combinations with anti-TNF-α provided sustained therapy success over 60 to 360 days. The triple combination of anti-TCR with anti-TNF-α plus anti-IL-1ß was most effective in regaining sustained normoglycaemia with an intact islet structure in a completely infiltration-free pancreas and with a normal beta cell mass. Besides the triple combination, the double antibody combination of anti-TCR with anti-TNF-α proved to be the most suited therapy for reversal of the T1D metabolic state due to effective beta cell regeneration in an infiltration free pancreas. KEY MESSAGES: Anti-TCR is a cornerstone in combination therapy for autoimmune diabetes reversal. The combination of anti-TCR with anti-TNF-α was most effective in reversing islet immune cell infiltration. Anti-TCR combined with anti-IL-1ß was not effective in this respect. The combination of anti-TCR with anti-TNF-α showed a sustained effect over 1 year.


Subject(s)
Antibodies, Monoclonal/pharmacology , Cytokines/antagonists & inhibitors , Diabetes Mellitus, Type 1/drug therapy , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Animals , Diabetes Mellitus, Type 1/etiology , Disease Management , Disease Models, Animal , Humans , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/metabolism , Rats , Receptors, Antigen, T-Cell/antagonists & inhibitors , T-Lymphocytes/metabolism
7.
J Med Invest ; 67(1.2): 211-213, 2020.
Article in English | MEDLINE | ID: mdl-32378612

ABSTRACT

Delta-shaped anastomosis is nowadays an increasingly performed reconstruction method in laparoscopic distal gastrectomy for early gastric cancer. To date, anastomotic recurrence at the delta-shaped anastomotic site has not been reported. Surgery for this disease is more complicated than anastomotic recurrence at the site of conventional Billroth-I anastomosis. A 68-year-old female was referred to our institute with early gastric cancer on the posterior wall of the antrum. She underwent laparoscopic distal gastrectomy with delta-shaped Billroth-I anastomosis. Follow-up gastrofiberscopy 16 months after the operation revealed suspected anastomotic recurrence, and gastric biopsy revealed signet-ring cell carcinoma. Open total gastrectomy with reconstruction with the Roux-en-Y method was performed. At the distal part of the previous anastomosis, an adequate length of the duodenum was dissected from the pancreas. Then, the duodenum was transected 3 cm distal to the anastomosis using a linear stapler. The patient recovered well and was discharged on postoperative day 14. The patient is alive without re-recurrence 3 years postoperatively. We successfully treated a patient with anastomotic recurrence of gastric cancer after delta-shaped anastomosis. Adequate resection of the duodenal stump was performed without any residual tumor or injury to the pancreas. J. Med. Invest. 67 : 211-213, February, 2020.


Subject(s)
Gastrectomy/methods , Laparoscopy/methods , Stomach Neoplasms/surgery , Aged , Anastomosis, Surgical/methods , Female , Humans , Neoplasm Recurrence, Local , Recurrence , Stomach Neoplasms/pathology
8.
In Vivo ; 34(2): 863-868, 2020.
Article in English | MEDLINE | ID: mdl-32111796

ABSTRACT

BACKGROUND/AIM: Neutrophil-to-lymphocyte ratio (NLR) is an indicator of systemic inflammation and could be a predictive factor in malignant tumors. The aim of this study was to investigate the impact of NLR in patients with lower rectal cancer who received preoperative chemo-radiotherapy (CRT). PATIENTS AND METHODS: Forty-eight patients with lower rectal cancer who underwent preoperative CRT and curative resection were enrolled. Blood samples were obtained before and after CRT. The relationship of NLR with clinical outcome was investigated. RESULTS: Post-CRT NLR was higher compared to pre-CRT NLR. The patients with higher post-CRT NLR tended to have worse pathological response to CRT compared to those with low post-CRT NLR. The patients with high post-CRT NLR showed poorer 5-year overall survival and 3-year disease free survival while there was no correlation according to pre-CRT NLR. The univariate analysis showed that post-CRT stage and post-CRT NLR were associated with a poorer 5-year overall survival. CONCLUSION: NLR after preoperative CRT could be a potential prognostic indicator for patients with lower rectal cancer.


Subject(s)
Chemoradiotherapy , Leukocyte Count , Lymphocytes , Neutrophils , Preoperative Care , Rectal Neoplasms/blood , Rectal Neoplasms/therapy , Aged , Aged, 80 and over , Biomarkers, Tumor , Chemoradiotherapy/adverse effects , Chemoradiotherapy/methods , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Neoplasm Staging , Preoperative Care/methods , Prognosis , Rectal Neoplasms/diagnosis , Rectal Neoplasms/mortality , Treatment Outcome
9.
BMC Med ; 18(1): 33, 2020 02 28.
Article in English | MEDLINE | ID: mdl-32106855

ABSTRACT

BACKGROUND: The cytokine IL-17 is a key player in autoimmune processes, while the cytokine IL-6 is responsible for the chronification of inflammation. However, their roles in type 1 diabetes development are still unknown. METHODS: Therefore, therapies for 5 days with anti-IL-17A or anti-IL-6 in combination with a T cell-specific antibody, anti-TCR, or in a triple combination were initiated immediately after disease manifestation to reverse the diabetic metabolic state in the LEW.1AR1-iddm (IDDM) rat, a model of human type 1 diabetes. RESULTS: Monotherapies with anti-IL-6 or anti-IL-17 showed no sustained anti-diabetic effects. Only the combination therapy of anti-TCR with anti-IL-6 or anti-IL-17 at starting blood glucose concentrations up to 12 mmol/l restored normoglycaemia. The triple antibody combination therapy was effective even up to very high initial blood glucose concentrations (17 mmol/l). The ß cell mass was raised to values of around 6 mg corresponding to those of normoglycaemic controls. In parallel, the apoptosis rate of ß cells was reduced and the proliferation rate increased as well as the islet immune cell infiltrate was strongly reduced in double and abolished in triple combination therapies. CONCLUSIONS: The anti-TCR combination therapy with anti-IL-17 preferentially raised the ß cell mass as a result of ß cell proliferation while anti-IL-6 strongly reduced ß cell apoptosis and the islet immune cell infiltrate with a modest increase of the ß cell mass only. The triple combination therapy achieved both goals in a complimentary anti-autoimmune and anti-inflammatory action resulting in sustained normoglycaemia with normalized serum C-peptide concentrations.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Interleukin-17/antagonists & inhibitors , Interleukin-6/antagonists & inhibitors , Remission Induction/methods , Animals , Disease Models, Animal , Female , Humans , Male , Rats , Rats, Inbred Lew
10.
Anticancer Res ; 40(1): 239-244, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31892572

ABSTRACT

BACKGROUND: In previous studies, we demonstrated the significant role of microRNA-449a (miR-449a) in colorectal cancer with in vivo and clinical samples. The importance of miR-449a in gastric cancer is still to be elucidated. This study examined the impact of miR-449a expression in tumor tissue and serum and investigated its potential as a prognostic marker in gastric cancer. MATERIALS AND METHODS: Sixty-six patients with gastric cancer who underwent surgery were included in the study. miR-449a expression in tumor tissue and serum were investigated by real-time polymerase chain reaction analysis. The association of miR-449a expression with clinicopathological factors and patient prognosis were also investigated. RESULTS: miR-449a expression was lower in tumor tissue than non-tumor tissue. miR-449a in tumor tissue negatively correlated with the malignancy of tumor and clinical stage. Increased carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels were seen at significantly higher frequencies in patients with low miR-449a expression. Patients with low miR-449a expression had poorer cancer-specific survival compared to those with high miR-449a expression. The univariate analysis showed that lymphovascular invasion, increased CEA and CA19-9 and a low expression of miR-449a were associated with a poorer 5-year cancer-specific survival. miR-449a expression level in serum correlated to that in tumor tissue and was also associated with tumor malignancy. CONCLUSION: The miR-449a level in tumor tissue might be useful as a prognostic indicator for patients with gastric cancer and miR-449a in serum appears to reflect its expression in tumor tissue.


Subject(s)
Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Stomach Neoplasms/genetics , Aged , Disease-Free Survival , Female , Humans , Male , MicroRNAs/blood , MicroRNAs/metabolism , Prognosis , Stomach Neoplasms/blood
11.
Surg Endosc ; 34(5): 1923-1928, 2020 05.
Article in English | MEDLINE | ID: mdl-31312962

ABSTRACT

INTRODUCTION: The pre-operative three-dimensional (3D) imaging technique has resulted in a better surgical outcome for patients and has been used as an education and diagnostic tool. However, there are no reports concerning the usefulness of the 3D imaging technique in laparoscopic transabdominal pre-peritoneal repair (TAPP) so the aim of this study was to investigate the usefulness of the 3D imaging technique in laparoscopic TAPP as an educational tool for medical students. PATIENTS AND METHODS: Six (6) patients who underwent laparoscopic TAPP for inguinal hernia were enrolled in this study. 3D reconstruction was performed from pre-operative computed tomography (CT) and the usefulness of pre-operative 3D simulation compared with intra-operative laparoscopic imaging was validated. Moreover, thirty (30) medical students at the university completed a multiple-choice questionnaire (MCQ) to determine the level of their satisfaction and understanding of anatomy resulting from the study. RESULT: The local anatomy of the patients was identified as the same during the operation as the pre-operative 3D simulation. The results of the MCQ showed that most of the medical students were extremely (23%) or very (67%) satisfied with the effect of pre-operative 3D simulation on the quality of the surgery. Moreover, most students could understand the surgery anatomy by the 3D simulation extremely well (40%) or very well (47%) and agreed on the usefulness of this procedure for learning anatomy. CONCLUSIONS: Pre-operative 3D simulation increases the understanding of detailed anatomy and virtual three-dimensional image analysis in laparoscopic TAPP is useful as an educational tool for medical students.


Subject(s)
Hernia, Inguinal/surgery , Imaging, Three-Dimensional/methods , Aged , Female , Humans , Male
12.
J Med Invest ; 66(3.4): 280-284, 2019.
Article in English | MEDLINE | ID: mdl-31656289

ABSTRACT

Purpose The aim of this study was to investigate the utility the three-dimensional (3D) imaging for laparoscopic gastrectomy performed by trainee surgeons. Methods 3D-reconstruction was performed using multi-detector computed tomography (MDCT) and SYNAPSE VINCENT software. Trainee surgeons made 3D-imaging and checked the anatomical structure. Thirty-three patients who underwent laparoscopic gastrectomy (LG) for gastric cancer were examined. Trainees performed 19 LG, while specialists performed 14 LG. The vascular pattern and the surgical outcomes were evaluated. Result 3D imaging depicted the correct positional relationship between the gastric vasculatures and the organs. Regarding vascular pattern detected by 3D imaging, the origins of the infrapyloric artery were the right gastroepiploic artery in 12 cases (36%), the gastroduodenal artery in eight cases (24%), the bifurcation of the right gastroepiploic artery and gastroduodenal artery in seven cases (21%), and not detected in one case (3%). The types of confluence of the infrapyloric vein were the right gastroepiploic vein in 16 cases (48%), the anterior superior pancreatoduodenal vein in 10 cases (30%), and not detected in seven cases (21%). Surgical outcomes were not different between trainee group using intraoperative 3D image with the specialist in instruction group without the intraoperative 3D image. Conclusions Preoperative 3D imaging might contribute to successful and safe LG by trainee surgeons. J. Med. Invest. 66 : 280-284, August, 2019.


Subject(s)
Gastrectomy/methods , General Surgery/education , Imaging, Three-Dimensional/methods , Laparoscopy/methods , Surgeons , Aged , Female , Humans , Male , Middle Aged , Multidetector Computed Tomography
13.
Anticancer Res ; 39(6): 2855-2860, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31177123

ABSTRACT

BACKGROUND: In a previous study, we demonstrated that deficiency of microRNA-449a (miR-449a) promoted colorectal tumorigenesis. In this study, the significance of miR-449a in the prognosis and relationship with HDAC1 in colorectal cancer was examined. MATERIALS AND METHODS: Seventy-two patients with colorectal cancer and 16 patients with colorectal liver metastasis who underwent surgery were included. miR-449a expression in tumor tissue of resected specimen was investigated by real-time polymerase chain reaction and histone deacetylase 1 (HDAC1) expression was examined by immunohistochemistry. RESULTS: Lymphovascular invasion and increased serum carcinoembryonic antigen levels were seen more frequent in patients with low miR-449a expression. Patients with low miR-449a expression were found to have a poorer prognosis than those with high expression. Vascular invasion, increased serum carbohydrate antigen 19-9 level and low miR-449a were associated with poorer disease-free survival. miR-449a expression was lower in metastatic liver tumor compared to primary tumor. HDAC1 positivity was higher in patients with low miR-449a. CONCLUSION: miR-449a level might be a prognostic indicator for colorectal cancer and miR-449a might regulate HDAC1 expression.


Subject(s)
Colorectal Neoplasms/surgery , Histone Deacetylase 1/metabolism , Liver Neoplasms/secondary , Liver Neoplasms/surgery , MicroRNAs/genetics , Aged , Antigens, Tumor-Associated, Carbohydrate/blood , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Female , Gene Expression Regulation, Neoplastic , Histone Deacetylase 1/genetics , Humans , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Male , Middle Aged , Neoplasm Invasiveness , Prognosis , Survival Analysis
14.
Anticancer Res ; 38(11): 6247-6252, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30396944

ABSTRACT

BACKGROUND/AIM: Epigallocatechin-3-gallate (EGCG) is a major polyphenolic component of green tea. EGCG plays a potential role in radio-sensitizing cancer cells. The combined effect of EGCG and radiation was investigated in a colorectal cancer cell line, focusing on nuclear factor (erythroid-derived 2)-like 2 (Nrf2) autophagy signalling. MATERIALS AND METHODS: HCT-116 cells were treated with 12.5 µM EGCG for different periods of time, 2 Gy radiation, or both. Cell viability was determined with the WST-8 assay. The number of colonies was determined with the colony formation assay. mRNA expression of LC3 and caspase-9 was analyzed with quantitative real-time polymerase chain reaction. RESULTS: Combination treatment with EGCG and radiation significantly decreased the growth of HCT-116 cells. The number of colonies was reduced to 34.2% compared to the control group. Immunofluorescence microscopy images showed that nuclear translocation of Nrf2 was significantly increased when cells were treated with the combination of EGCG and radiation compared to the control and single-treatment groups. Combined treatment with EGCG and radiation significantly induced LC3 and caspase-9 mRNA expression. CONCLUSION: EGCG increased the sensitivity of colorectal cancer cells to radiation by inhibiting cell proliferation and inducing Nrf2 nuclear translocation and autophagy.


Subject(s)
Catechin/analogs & derivatives , Colorectal Neoplasms/metabolism , NF-E2-Related Factor 2/metabolism , Radiation-Sensitizing Agents/pharmacology , Caspase 9/genetics , Catechin/pharmacology , Cell Nucleus/metabolism , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Cell Survival , Colorectal Neoplasms/genetics , Colorectal Neoplasms/therapy , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/radiation effects , HCT116 Cells , Humans , Microtubule-Associated Proteins/genetics , NF-E2-Related Factor 2/genetics , Protein Transport/drug effects , Protein Transport/radiation effects , Transcriptional Activation/drug effects , Transcriptional Activation/radiation effects
15.
Anticancer Res ; 38(6): 3367-3373, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29848685

ABSTRACT

BACKGROUND/AIM: Programmed cell death protein 1 (PD-1)/ programmed cell death ligand 1(PD-L1) axis is associated with immune tolerance via inhibition of T cell activation. The aim of this study was to clarify the significance of PD-1 and PD-L1 expressions and analyze the relationships between PD-1, PD-L1, transforming growth factor-ß (TGF-ß) and Forkhead box P3 (Foxp3) expressions in colorectal cancer (CRC). PATIENTS AND METHODS: A total of 116 patients who underwent curative colectomy for stage II/III CRC were included in the study. PD-1, PD-L1, TGF-ß, and Foxp3 expressions were examined by immunohistochemistry and related to prognostic factors by Kaplan-Meier. RESULTS: PD-1 expression was correlated with PD-L1, TGF-ß, and Foxp3 expressions. Overall survival rates were significantly poorer in the PD-1 and PD-L1-positive groups. Multivariate analysis showed that PD-L1-positive is an independent risk factor. Disease-free survival (DFS) was tended in the PD-L1-positive group. The group with double-positive expression had significantly poorer prognosis. CONCLUSION: PD-1 and PD-L1 expressions were associated with a poor prognosis and correlated with TGF-ß and Foxp3 expressions in patients with CRC.


Subject(s)
B7-H1 Antigen/biosynthesis , Colorectal Neoplasms/metabolism , Programmed Cell Death 1 Receptor/metabolism , Adult , Aged , Aged, 80 and over , Colectomy/methods , Colorectal Neoplasms/surgery , Female , Forkhead Transcription Factors/metabolism , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Prognosis , Transforming Growth Factor beta/metabolism
16.
Anticancer Res ; 38(6): 3387-3392, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29848687

ABSTRACT

BACKGROUND/AIM: Indoleamine 2,3-dioxygenase (IDO) down-regulates T cell activation, attenuates regulatory T cell (Treg) activation and is related to immune tolerance. The aim of the study was to clarify the significance of IDO expression and analyze the relationships between the expression of IDO, TGF-ß, and Foxp3 in gastric cancer (GC). PATIENTS AND METHODS: A total of 60 patients who underwent curative gastrectomy for stage III gastric cancer were included in the study. The expression of IDO, TGF-ß, and Foxp3 was examined by immunohistochemistry and the relationship of each expression level to several prognostic factors was examined using univariate and multivariate analyses. RESULTS: IDO expression was not positively correlated with any of the factors examined. IDO expression was positively correlated with TGF-ß expression (p<0.05), and TGF-ß expression was positively correlated with FoxP3 expression (p<0.05). Overall survival (OS) rates were significantly poorer in the IDO-positive group compared to the IDO-negative group (3-year OS, 78.5% vs. 90%, respectively; p<0.05). Multivariate analysis confirmed IDO expression as independent prognostic factors in OS. Disease-free survival (DFS) was significantly poorer in the IDO-positive group compared to the IDO-negative group (3-year DFS, 59.3% vs. 69.3%, respectively; p<0.05). CONCLUSION: IDO is associated with poor prognosis and immuno-tolerance through attenuation of Treg activation in Stage III GC.


Subject(s)
Indoleamine-Pyrrole 2,3,-Dioxygenase/biosynthesis , Stomach Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Female , Forkhead Transcription Factors/metabolism , Gastrectomy , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prognosis , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta1/metabolism
17.
J Med Invest ; 65(1.2): 27-31, 2018.
Article in English | MEDLINE | ID: mdl-29593189

ABSTRACT

BACKGROUND: Surgical indication for hepatic resection is controversial in gastric cancer liver metastasis (GLM). The aim of this study is to clarify the effect of hepatic resection for GLM. METHODOLOGY: Ten patients who underwent hepatic resection for GLM between 2001 and 2013 were enrolled in this study. Six patients underwent synchronous hepatic resection and gastrectomy, and the remaining four patients underwent metachronous hepatic resection. Six patients had solitary liver metastasis, and 4 patients had multiple liver metastasis. The median follow-up period was 12.4 months (the range being 0.5 months to 50 months). RESULT: The actual 1- year and 3-year overall survival rates for the patients who underwent hepatic resection are 88.9% and 17.8%, respectively. The median survival time was 21.5 months. And the 1-year recurrence free survival time was 20.0%. The median recurrence free survival rate was 4.7 months. Regarding post-operative recurrence, synchronous hepatic resection tended to be a recurrence factor (p=0.08). CONCLUSION: Hepatic resection for GLM has an acceptable outcome. Metachronous hepatic resection tends to have a better outcome than synchronous hepatic resection for the treatment of GLM. J. Med. Invest. 65:27-31, February, 2018.


Subject(s)
Hepatectomy , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Stomach Neoplasms/pathology , Aged , Aged, 80 and over , Female , Humans , Liver Neoplasms/mortality , Male , Middle Aged
18.
Int J Clin Oncol ; 23(1): 98-103, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28875240

ABSTRACT

BACKGROUND: Microvascular invasion (mvi) is an important risk factor for recurrent hepatocellular carcinoma (HCC), even after curative liver resection or orthotopic liver transplantation. However, mvi is difficult to detect preoperatively. The aim of this study was to clarify the risk factors of postoperative recurrence and investigate predictive factors of mvi before hepatectomy for HCC classified within the Milan criteria. METHODS: One hundred fifty-nine patients with hepatocellular carcinoma (HCC) classified within the Milan criteria, who underwent hepatectomy, were enrolled in this study. We investigated the risk factors of recurrence. In addition, we divided them into two groups: mvi-negative group and mvi-positive group, based on pathological findings after surgery. We compared the clinicopathological factors between the two groups and determined the risk factors for mvi. RESULTS: Overall survival rate at 1, 3, and 5 years were 91.6%, 80.5%, and 74.9%, and the recurrence-free survival rate at 1, 3, and 5-years were 72.3%, 51.6%, and 37.2%. Risk factor analysis for tumor recurrence revealed that total bilirubin, albumin, ICGR15, AFP-L3, tumor number, mvi, and tumor stage had a significant predictive value. Multivariate analysis revealed that tumor number and mvi were significant independent risk factors for tumor recurrence. Predictive analysis for risk factors of mvi revealed that multiple tumors and AFP-L3 > 10% were significant independent risk factors for mvi in HCC classified within the Milan criteria. CONCLUSIONS: The mvi was one of the independent risk factors for tumor recurrence in HCC classified within the Milan criteria. Multiple tumors and high AFP-L3 value were independent predictive factors for mvi.


Subject(s)
Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/surgery , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Aged , Bilirubin/blood , Disease-Free Survival , Female , Hepatectomy/mortality , Humans , Male , Middle Aged , Multivariate Analysis , Neoplasm Recurrence, Local/pathology , Retrospective Studies , Risk Factors , Survival Rate
19.
Anticancer Res ; 38(1): 501-507, 2018 01.
Article in English | MEDLINE | ID: mdl-29277815

ABSTRACT

BACKGROUND/AIM: We report the outcomes of sorafenib therapy for advanced hepatocellular carcinoma (HCC) in our Department. PATIENTS AND METHODS: Thirty-eight patients with unresectable HCC who were administrated sorafenib from 2009 to 2015 were investigated retrospectively. RESULTS: The 1-year overall survival rate was 59.3%. The macroscopic vascular invasion and response rate were independent prognostic factors of survival. Surgical resection after sorafenib achieved long-term survival in two cases. Case 1: A patient with locally unresectable HCC showed significant response induced by sorafenib, which allowed complete surgical resection. This tumor tested positive for FGF4. Case 2: A patient with a history of hepatectomy for HCC had multiple distant metastases. Most lesions were reduced in size after sorafenib therapy and new lesions in the remnant liver and residual lung metastases were resected. The sorafenib-resistant lesions were negative for FGF4. CONCLUSION: Sorafenib combined with surgical resection is a feasible option in advanced HCC patients, if sorafenib has been effective.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/surgery , Hepatectomy , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Niacinamide/analogs & derivatives , Phenylurea Compounds/therapeutic use , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/pathology , Combined Modality Therapy , Female , Fibroblast Growth Factor 4/metabolism , Hepatitis B/complications , Humans , Liver Neoplasms/pathology , Male , Middle Aged , Niacinamide/therapeutic use , Retrospective Studies , Salvage Therapy , Sorafenib , Survival Rate
20.
Surg Laparosc Endosc Percutan Tech ; 28(2): e40-e43, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29064880

ABSTRACT

PURPOSE: Many reconstruction techniques have been reported after laparoscopic total gastrectomy (LTG), but it is not clear which anastomosis technique is most useful, and no standard methods have been established. This study examined whether LTG using the transoral anvil delivery system (TOADS) is a feasible and safe procedure for gastric cancer. MATERIALS AND METHODS: A series of 47 patients underwent the overlap method and 36 underwent the hemi-double-stapling technique with TOADS. Intraoperative and postoperative outcomes were compared between the 2 groups. RESULTS: In the TOADS group, operation time for reconstruction was shorter (16±3 vs. 45±10 min, P=0.003), and blood loss was reduced (45±15 vs. 126±13 mL, P=0.0002). There were no significant differences in intraoperative complications, conversion to open surgery, and intraoperative anastomosis-related complications between the 2 groups. Furthermore, there were no significant differences in the incidence of complications, reoperation, mortality, and postoperative hospital stay. CONCLUSION: LTG using TOADS for gastric cancer may be a technically feasible surgical procedure with acceptable morbidity.


Subject(s)
Esophagostomy/instrumentation , Gastrectomy/adverse effects , Jejunostomy/instrumentation , Laparoscopy/adverse effects , Natural Orifice Endoscopic Surgery/instrumentation , Postoperative Complications/surgery , Stomach Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Gastrectomy/methods , Humans , Male , Middle Aged , Mouth , Operative Time , Reoperation , Retrospective Studies , Suture Techniques , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...